­
medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2001, Number 2

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2001; 14 (2)

Protective immune response to Mycobacterium tuberculosis infection.

García-Sancho FMCE

Language: Spanish
References: 109
Page: 114-128
PDF size: 235.81 Kb.


Text Extraction

No abstract


REFERENCES

  1. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:807-808.

  2. Milburn HJ. Primary tuberculosis. Curr Opin Pulm Med 2001;7:133-141.

  3. Riley LW. Determinants of cell entry and intracellular survival of Mycobacterium tuberculosis. Trends Microbiol 1995;3: 27-31.

  4. Daniel TM, Ellner JJ. Immunology of tuberculosis. In: Lee BR, Earl SH, editors. Tuberculosis. A comprehensive international approach. Lung biology in health and disease. New York: Marcel Dekker: 1993.

  5. Munk ME, Kaufmann SH. The immune response to Mycobacterium tuberculosis. Behring Inst Mitt 1991;88:27-35.

  6. Yoshida N. Role of gamma/delta T-cells in the peripheral blood of patients with pulmonary tuberculosis. Kurume Med J 2001;48:175-181.

  7. Cooper AM, D´Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin -or granzyme-mediated cytolytic mechanisms. Infect Immun 1997;65:1317-1320.

  8. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.

  9. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1986;55:663-700.

  10. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 1978;75: 3327-3331.

  11. Harth G, Clemens DL, Horwitz MA. Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci USA 1994;91:9342-9346.

  12. Harth G, Horwitz MA. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 1999;189:1425-1435.

  13. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;5:323-350.

  14. Chan J, Flynn JL. Nitric oxide in Mycobacterium tuberculosis infection. In: Nitric oxide and infection. New York: Plenum, 1999:281-310.

  15. Nicholson S, Bonecini-Almeida M, Lapa e Silva JR, Nathan C, Xie QW, Mumford R, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-2302.

  16. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998;11:809-815.

  17. Walker L, Lowrie DB. Killing of Mycobacterium microti by immunologically activated macrophages. Nature 1981; 293: 69-70.

  18. Flesch I, Kaufmann S. Mycobacterial growth inhibition by interferon-gamma activated bone marrow magrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138:4408-4413.

  19. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-1122.

  20. Chan J, Fujiwara T, Brennan P, McNeil M, Turco SJ, Sibille JC, et al. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 1989; 86: 2453-2457.

  21. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999;285:732-736.

  22. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptors-2 mediates mycobacteria-induced proinflamatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96: 14459-14463.

  23. Ladel CH, Szalay G, Reidel D, Kaufmann SHE. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect Immun 1997;65:1936-1938.

  24. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997;159:635-643.

  25. Cooper AM, Roberts AD, Roades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995; 84:423-432.

  26. Ottenhoff TH, Kumararatne D, Casanova JL. Novel human immunodeficiencies reveal the essential role of type-1-citokines in immunity to intracellular bacteria. Immunol Today 1998;19:491-494.

  27. Lowrie DB, Tascon RE, Bonato VLD, Lima VMF, Faccioli LH, Stavropoulos E, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999;400:269-271.

  28. Lyadova I, Yeremeev V, Majorov K, Nikonenko B, Khaidukov S, Kondratieva T, et al. An exvivo study of T lymphocytes recovered from the lungs of l/St mice infected with and susceptible to Mycobacterium tuberculosis. Infect Immun 1998;66:4981-4988.

  29. Lalvani A, Brookes R, Wilkinson R, Malin A, Pathan A, Andersen P, et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998;95:270-275.

  30. Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon-gamma gene disrupted mice. J Exp Med 1993; 178: 2243-2248.

  31. Fenhalls G, Wong A, Bezuidenhout J, van Helden P, Bardin P, Lukey PT. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granuloma. Infect Immun 2000; 68: 2827-2836.

  32. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 1996;64:1351-1356.

  33. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-3234.

  34. Hernandez PR, Pavon L, Arriaga K, Orozco H, Madrid MV, Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect Immun 1997;65:3317-3327.

  35. Flynn Jl, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-a is required in the protective immune response against M. tuberculosis in mice. Immunity 1995;2:561-572.

  36. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999;162:3504-3511.

  37. Liew FY, Li Y, Millott S. Tumor necrosis factor-a synergizes with IFN-g in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 1990;145:4306-4310.

  38. Rook GAW, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987;62:229-234.

  39. Rook GAW. Mycobacteria, cytokines and antibiotics. Pathol Biol (Paris) 1990; 38: 276-280.

  40. Moreira AL, Tsenova-Berkova L, Wang J, Laochumroonvorapong P, Freeman S, Freedman GK. Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis. Tuber Lung Dis 1997;78:47-55.

  41. Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Burdick MD, Strieter RM, et al. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA 1998;95:13806-13811.

  42. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial . ATTRACT Study Group. Lancet 1999;354:1932-1939.

  43. Gong J-H, Zhang M, Modlin RL, Linsley PS, Iyer D, Ling Y, et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64:913-918.

  44. Rojas M, Olivier M, Gros P, Barrera LF, Garcia LF. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J Immunol 1999;162:6122-6131.

  45. VanHeyningen TK, Collins HL, Russell DG. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 1997;158:330-337.

  46. Ladel CH, Blum C, Dreher A, Reinfenberg K, Kopf M, Kaufmann SHE. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997;65:4843-4849.

  47. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 1997;94:3926-3931.

  48. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculosis granulomatous lung lesions. J Immunol 1995;154:465-473.

  49. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabnomannan of Mycobacterium tuberculosis. Infect Immun 1996;64:399-405.

  50. Rojas RE, Balaji KN, Subramanian A, Boom WH. Regulation of human CD+ alphabeta T-cell-receptor-positive TCR(+) and gammadelta TCR(+) T cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. Infect Immun 1999;67:6461-6472.

  51. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors beta 1-beta2 and beta3 factor inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol 1990;145:940-944.

  52. Serbina NV, Liu CC, Scanga CA, Flynn JL. CD8+ cytotoxic T lymphocytes from lungs of M. tuberculosis infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000;165:353-563.

  53. Feng CG, Bean AG, Hooi H, Briscoe H, Britton WJ. Increase in gamma interferon-secreting CD8(+), as well as CD4 T (+) cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun 1999;67:3242-3247.

  54. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class-I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-12017.

  55. Randhawa PS. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 1990;22:153-155.

  56. Muller I, Cobbold SP, Waldmann H, Kaufmann SH. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immunol 1987;55:2037-2041.

  57. Teitelbaum R, Glatman-Freedman A, Chen B, Robbins JB, Unanue E, Casadevall A, et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 1998;95:15688-15693.

  58. Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ. Protection against Mycobacterium tuberculosis infection by CD8(+) cells requires production of gamma interferon. Infect Immun 1998;66:830-834.

  59. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently dimi-nished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999;162:5407-5416.

  60. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 1989; 320:545-350.

  61. Oddo M, Renno T, Attainger A, Bakker T, MacDonald HR, Meylan PR. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998;160:5448-5454.

  62. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, Chan J, et al. Depletion of CD4(+) cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide sinthase 2. J Exp Med 2000;192:347-358.

  63. Clarke SRM. The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ cell immunity. J Leukoc Biol 2000;67:607-614.

  64. Andreasen SO, Christensen J, Marker O, Thomsen AR. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol 2000; 164:3689-3697.

  65. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998;188:2199-2204.

  66. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2 resulting in inac-tivation of TNF-a. J Immunol 1998;161:2636-2641.

  67. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton MJ, et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997;65:298-304.

  68. Silva CL, Lowrie DB. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect Immun 2000;68:3269-3274.

  69. Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, et al. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1996;93:11786-11791.

  70. Hmama Z, Gabathuler R, Jefferies WA, Dejong G, Reiner NE. Attenuation of HLA_DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J Immunol 1998;161:4882-4893.

  71. Stenger S, Niazi KR, Modlin RL. Down-regulation of CD1 on antigen presenting cells by infection with Mycobacterium tuberculosis. J Immunol 1998;161:3582-3588.

  72. McDonough KA, Kress Y, Bloom BR. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993;61:2763-2773.

  73. Lalvani A, Brookes R, Wilkinson R, Malin A, Pathan A, Andersen P, et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998;95:270-275.

  74. De Libero G, Flesch I, Kaufmann SH. Mycobacteria-reactive Lyt-2+ T cell lines. Eur J Immunol 1988;18:59-66.

  75. Albert M, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class-I restricted CTLs. Nature 1998;392:86-89.

  76. Serbina NV, Flynn JL. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 1999;67:3980-3988.

  77. Zhu X, Stauss HJ, Ivanyi J, Vordermeier HM. Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis. Int Immunol 1997;9:1669-1676.

  78. Sieling PA, Ochoa MT, Jullien D, Leslie DS, Sabet S, Rosat JP, et al. Evidence for human CD4+ T cells in the CD1-res-tricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol 2000;164:4790-4796.

  79. Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19kDa lipoprotein. J Immunol 1998; 161:2400-2406.

  80. Teitelbaum R, Cammer M, Maitland ML, Freitag NE, Condeelis J, Bloom BR. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci USA 1999;96:15190-15195.

  81. Sugita M, Grant EP, van Donselaar E, Hsu VS, Rogers RA, Peters PJ, et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999;11:743-752.

  82. Schaible UE, Hagens K, Fischer K, Collins HL, Kaufmann SH. Intersection of Group 1 CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J Immunol 2000;164:4843-4852.

  83. Briken V, Jackman RM, Watts GF, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000;192:281-287.

  84. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, Russell DG. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 2000;1:235-247.

  85. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta + T cells. Nature 1994;372:691-694.

  86. Porcelli A, Morita CT, Brenner MB. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature 1992;360:593-587.

  87. Moody DB, Ulrichs T, Muhlecker W, Young DC, Gurcha SS, Grant E, et al. CD1c-mediated T-cell recognition of

  88. isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000;404:884-888.

  89. Sieling PA, Jullien D, Dahlem M, Tedder TF, Rea TH, Modlin RL, et al. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol 1999;162:1851-1858.

  90. Kaufmann SH. T lymphocytes in intracellular microbial infections. Immunol Today 1988;9:168-174.

  91. Kaufmann SHE. Immunity to intracellular bacteria. Annu Rev Immunol 1993;11:129-163.

  92. Ho S, Mehra V, Thoma-Uszynski S, Stenger S, Serbina N, Mazzaccaro RJ, et al. Antimicrobial activity of MHC class I restricted CD8 + T cells in human tuberculosis. Proc Natl Acad Sci USA 2000;97:12210-12215.

  93. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazt KR, Froelich CJ, et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998;282:121-125.

  94. Laochumroonvorapong P, Wang J, Liu CC, Ye W, Moreira AL, Elkon KB, et al. Perforin, a citotoxic molecule which me-diates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997;65: 127-132.

  95. Matloubian M, Suresh M, Glass A, Galvan M, Chow K, Whitmire JK, et al. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999;73:2527-2536.

  96. Johnson CM, Cooper AM, Frank AA, Orme IM. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 1998;66:1666-1670.

  97. Bonecchi R, Bianchi G, Bordignon PP, D´ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.

  98. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.

  99. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-312.

  100. Rhoades ER, Cooper AM, Orme IM. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995;63:3871-3877.

  101. Ellner JJ, Hirsch CS, Whalen CC. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis 2000;30 Suppl 3:S279-S282.

  102. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998;2:443-450.

  103. Demissie A, Ravn P, Olobo J, Doherty TM, Eguale T, Geletu M, et al. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts. Infect Immun 1999;67:5967-5971.

  104. Schwander SK, Torres M, Carranza CC, Escobedo D, Tary-Lehmann M, Anderson P, et al. Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J Immunol 2000;165:1479-1485.

  105. Vakemans J, Lienhardt C, Sillah JS, Wheeler JG, Lahai GP, Doherty MT, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69:6554-6557.

  106. Fjallbrant H, Ridell M, Larsson LO. The tuberculin skin test in reaction to immunological in vitro reactions in BCG vaccinated healthcare workers. Eur Respir J 2001;18:376-380.

  107. Katial RK, Hershey J, Purohit-Seth T, Belisle JT, Brennan PJ, Spencer JS, et al. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture. Clin Diagn Lab Immunol 2001;8:339-345.

  108. Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001;5:462-267.

  109. Converse PJ, Jones SL, Astemborski J, Vlahov D, Graham NM. Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults. Effect of human immunodeficiency virus infection. J Infect Dis 1997; 176:144-150.




2020     |     www.medigraphic.com

    Este sitio utiliza cookies   Estoy de acuerdo